A growing evidence base shows that chronic obstructive pulmonary disease (COPD) is affected by climate and environmental exposures, not only through extreme temperature exposure and air pollution but ...

“Compared to non-CMR recipients, CMR recipients experienced a considerably higher increase in adherence to COPD medications from 2016 to 2017, and findings with data from more recent years are ...

Some people with chronic obstructive pulmonary disease (COPD) need to use multiple inhaled medicines each day to control their symptoms. Long-acting combination inhalers that contain more than one ...

People living with chronic obstructive pulmonary disease (COPD) typically rely on maintenance inhalers to manage their daily symptoms. They may also take rescue inhalers for sudden breathing ...

Stephanie A. Christenson, MD, MAS, summarizes core data presented at the 2024 American Thoracic Society (ATS) International Conference, including data on some promising biologics, like dupilumab and ...

Trelegy Ellipta (fluticasone furoate/umeclidinium/vilanterol) is a prescription drug used to treat COPD. With COPD, you have lung damage that worsens over time ...

The 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report highlighted climate change, cardiovascular risk, and pulmonary hypertension. Claus F. Vogelmeier, MD, chair of the GOLD ...

Please provide your email address to receive an email when new articles are posted on . Fewer patients with COPD experienced altitude-related adverse health effects at 3,100 m with acetazolamide vs.

Chronic Obstructive Pulmonary Disease (COPD) is the fourth leading cause of death, causing 3.5 million deaths globally in the year 2021. COPD is a common lung disease that restricts airflow and causes ...